Elligo: Michael Gibertini, CDO
Elligo Health Research has appointed Michael Gibertini chief development officer. His responsibilities include developing new lines of business that support the company’s work to elevate clinical research as a patient care option.
Prior to joining Elligo, Gibertini worked more than 30 years in the life-sciences field, most recently as president of clinical development at Syneos Health.
John Potthoff, CEO of Elligo, said, “The role of chief development officer is integral to developing new lines of business that help us achieve our mission. He is already making a positive impact in our efforts to prioritize research as a healthcare option for our diverse pool of patients.”